Skip to content

Clinical trials

Completed Multiple Myeloma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: Canada Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20024
20032
20042
20053
20066
20073
20087
20095
20106
201110
20127
20139
20147
20155
201611
20179
20188
20193
20202
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen13
Celgene11
Janssen Research & Development, LLC9
Bristol-Myers Squibb7
NCIC Clinical Trials Group6
GlaxoSmithKline5
Millennium Pharmaceuticals, Inc.5
University Health Network, Toronto5
Novartis Pharmaceuticals4
Takeda4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma123
Neoplasms, Plasma Cell21
Recurrence20
Lymphoma8
Hematologic Neoplasms6
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Neoplasms5
Hodgkin Disease4
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.